AmyriAD

AmyriAD Therapeutics B.V. is a biopharmaceutical company striving to advance effective therapies for Alzheimer's disease (AD). The company is developing drug treatments combined with cutting-edge diagnostics, digital staging assessments, and disease-modifying strategies. Our team brings together decades of experience in Alzheimer's disease, with the sole aim of alleviating the devastation it causes.